Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease (2012)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- Subjects: BIOMARCADORES; INSUFICIÊNCIA RENAL CRÔNICA; METALOPROTEINASES; POLIMORFISMO; ESTUDOS DE CASOS E CONTROLES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: American Journal of Nephrology
- ISSN: 0250-8095
- Volume/Número/Paginação/Ano: v. 35, n. 3, p. 209-215, 2012
-
ABNT
MARSON, Bernardo P.; LACCHINI, Riccardo; BELO, Vanessa; et al. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease. American Journal of Nephrology, Basel, v. 35, n. 3, p. 209-215, 2012. Disponível em: < http://dx.doi.org/10.1159/000336108 >. -
APA
Marson, B. P., Lacchini, R., Belo, V., Dickel, S., Costa, B. P. da, Figueiredo, C. E. P. de, & Tanus-Santos, J. E. (2012). Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease. American Journal of Nephrology, 35( 3), 209-215. Recuperado de http://dx.doi.org/10.1159/000336108 -
NLM
Marson BP, Lacchini R, Belo V, Dickel S, Costa BP da, Figueiredo CEP de, Tanus-Santos JE. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease [Internet]. American Journal of Nephrology. 2012 ; 35( 3): 209-215.Available from: http://dx.doi.org/10.1159/000336108 -
Vancouver
Marson BP, Lacchini R, Belo V, Dickel S, Costa BP da, Figueiredo CEP de, Tanus-Santos JE. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease [Internet]. American Journal of Nephrology. 2012 ; 35( 3): 209-215.Available from: http://dx.doi.org/10.1159/000336108 - The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
- Endothelial nitric oxide synthase: from biochemistry and gene structure to clinical implications of NOS3 polymorphisms
- Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension
- Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril
- Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients
- Endothelial nitric oxide synthase haplotypes associated with hypertension do not predispose to cardiac hypertrophy
- Inducible nitric oxide synthase haplotype associated with hypertension and responsiveness to antihypertensive drug therapy
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
